The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Allele-specific KRAS mutations as prognostic biomarkers in mucinous adenocarcinoma of the appendix and colorectal cancer.
 
Moh'd M. Khushman
Stock and Other Ownership Interests - Cardiff Oncology
Consulting or Advisory Role - Cardinal Health; Muerus; TriSalus Life Sciences
Speakers' Bureau - Caris Life Sciences
Research Funding - Abbvie (Inst); FOGPharma (Inst); IgM Biosciences (Inst); Torl Biotherapeutics (Inst)
 
Hassan Mohammed Abushukair
No Relationships to Disclose
 
Sanad Alhushki
No Relationships to Disclose
 
Michael Iglesia
No Relationships to Disclose
 
Kian-Huat Lim
Honoraria - CURIS
Patents, Royalties, Other Intellectual Property - Hold patent for targeting MK2 as a therapeutic strategy in pancreatic cancer.
 
Xiuli Liu
No Relationships to Disclose
 
Nikolaos Trikalinos
Research Funding - Bristol-Myers Squibb (Inst); Elevar Therapeutics (Inst); Exelixis (Inst); Merck (Inst); Novartis (Inst); Nykode Therapeutics (Inst)
 
Rama Suresh
No Relationships to Disclose
 
Olivia Aranha
Consulting or Advisory Role - Seagen
Research Funding - Compass Therapeutics (Inst); Ipsen (Inst); Merck (Inst); Pfizer (Inst)
 
Patrick Grierson
Employment - Walgreens (I)
Patents, Royalties, Other Intellectual Property - Compositions and Methods for the Treatment of Pancreatic Cancer
 
Benjamin R. Tan
Research Funding - Abbvie (Inst); Adaptimmune (Inst); Agios (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck Serono (Inst); Tvardi Therapeutics (Inst); TYME (Inst)
 
Katrina Sophia Pedersen
Honoraria - OncLive/MJH Life Sciences; Takeda
Consulting or Advisory Role - Array BioPharma; Artemida Pharma; AstraZeneca; Bayer; Bristol Myers Squibb; GlaxoSmithKline; Guardant Health; Incyte; Novartis; Pfizer; SAGA Diagnostics; Taiho Oncology; Tempus
Speakers' Bureau - WebMD
Research Funding - Abbvie (Inst); Arcus Biosciences (Inst); Biomea Fusion (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Cardiff Oncology (Inst); Daiichi Sankyo/Lilly (Inst); HCW Biologics (Inst); Incyte (Inst); Ipsen (Inst); Merck (Inst); Natera (Inst); Nouscom (Inst); Novartis (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Array BioPharma; BeiGene; GlaxoSmithKline; NCCN; Nouscom
Other Relationship - UpToDate
(OPTIONAL) Uncompensated Relationships - NCCN